5 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... - 4–6 weeks Alternatives ... year Alternatives ... Meningoencephalitis #IDSA ... #Treatment #management
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... day) 2 weeks Alternatives ... day) 6 months to 1 ... Meningoencephalitis #IDSA ... #Treatment #management
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... Epidemiology: • #1 ... often ordered in reflex ... bid x 10d - Alternative ... 10 mg/kg IV x 1
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... daily (AI), or Alternative ... Refer to product ... 4–6 mL QID or 1– ... Prevention #Treatment #management
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... weekly (BIII) Alternative ... interactions, please refer ... Mycobacterium #AviumComplex ... #Treatment #management